表纸
市场调查报告书

全球血浆市场(免疫球蛋白,白蛋白,第八凝血因子,Alpha-1)洞察,趋势,预测

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

出版商 Koncept Analytics 商品编码 897440
出版日期 内容资讯 英文 109 Pages
订单完成后即时交付
价格
Back to Top
全球血浆市场(免疫球蛋白,白蛋白,第八凝血因子,Alpha-1)洞察,趋势,预测 Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)
出版日期: 2019年07月30日内容资讯: 英文 109 Pages
简介

本报告提供全球血浆市场调查,市场概要,各市场区隔的市场预测,市场成长要素及课题分析,竞争情形,主要企业的简介等全面性资讯。

第1章 市场概要

  • 血浆
  • 血浆分馏流程
  • 血浆衍生物
  • 血浆功能
  • 等离子收集

第2章 全球市场分析

  • 血浆市场(以金额为准)
  • 血浆市场预测(以金额为准)
  • 血浆分馏容量(公升为基础)
  • 血浆分馏产能预测
  • 血浆分馏容量:各类型
  • 血浆分馏产能预测:各类型
  • 血浆市场:各类型
  • 血浆市场预测:各类型
  • 免疫球蛋白市场
  • 白蛋白市场
  • 第八凝血因子
  • Alpha-1
  • 血浆市场:各地区

第3章 地区市场分析

  • 北美
    • 血浆市场预测
    • 血浆市场:各类型
    • 美国的免疫球蛋白市场预测(以金额、重量为准)
    • 美国的免疫球蛋白市场:各市场区隔
    • 美国的白蛋白市场预测
    • 美国的原料血浆采取市场
    • 美国的原料血浆采取市场预测
  • 欧洲
    • 欧洲的血浆市场预测
  • 亚太地区
    • 亚太地区的血浆市场预测

第4章 市场动态

  • 成长促进因素
  • 市场趋势
  • 课题

第5章 竞争情形

  • 全球市场
    • 收益及市值比较
    • 研究开发支出比较
    • 全球血浆市场占有率
    • 全球免疫球蛋白市场占有率
    • 全球白蛋白市场占有率
    • 全球血浆来源第八凝血因子市场占有率
    • Alpha-1市场占有率
    • 主要企业的血浆采取的增加
  • 美国
    • 美国的血浆采取中心:各主要企业
    • 美国的血浆采取数量:各主要企业

第6章 企业简介

  • 武田药品工业
  • CSL Limited
  • Frifols, S.A.
  • Octapharma, Inc.
  • ADMA Biologics, Inc.
  • China Biologics Product Holdings
目录

The global blood plasma market is estimated to reach US$29.50 billion in 2023, growing at a CAGR of 7% for the period spanning from 2019 to 2023. The factors such as progress in therapeutic protein development, new advances in production of plasma, growing aging population, increasing spending on medicines and rise in collection centers are expected to drive the market. However, growth of the industry will be challenged by high cost of treatment, and high R&D costs. A few notable trends include increase in fractionation capacity, and innovation in therapeutics.

The global blood plasma market is broadly segmented into four types which are Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. Increased recognition and treatment of primary immunodeficiency (PI), use in new indications, and increasing consumption in low IG-use countries has driven the growth of immunoglobulin segment.

North America is the largest market for blood plasma due to its advanced infrastructure which has helped in increasing plasma collection over the time. The emerging economies like China have showed huge potential with increased imports of Albumin. Rising use of immunoglobulin and increasing incidence of immune and bleeding disorders propelled the demand for immunoglobulin in the Unites States.

Scope of the report:

The report provides a comprehensive analysis of the global blood plasma market, segmented into Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others.

The major regional markets (North America, Europe and APAC) have been analyzed, along with country coverage of the United States.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Takeda Pharmaceutical, CSL Limited, Grifols S.A., Octapharma, Inc., ADMA Biologics and China Biologics) are also presented in detail.

Key Target Audience:

  • Blood Plasma Products Manufacturers
  • End Users (Hospitals, Medical Centers & Clinical Institutes)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Blood Plasma
  • 1.2 Blood Plasma Fractionation Process
  • 1.3 Blood Plasma Derivatives
  • 1.4 Functions of Blood Plasma
  • 1.5 Plasma Collection

2. Global Market Analysis

  • 2.1 Global Blood Plasma Market by Value
  • 2.2 Global Blood Plasma Market Forecast by Value
  • 2.3 Global Blood Plasma Fractionation Capacity
  • 2.4 Global Blood Plasma Fractionation Capacity Forecast
  • 2.5 Global Blood Plasma Fractionation Capacity by Type
  • 2.6 Global Blood Plasma Fractionation Capacity Forecast by Type
  • 2.7 Global Blood Plasma Market by Type
  • 2.8 Global Blood Plasma Market Forecast by Type
  • 2.9 Global Immunoglobulin Market
    • 2.9.1 Global Immunoglobulin Market Forecast by Value
    • 2.9.2 Global Immunoglobulin Market Forecast by Volume
    • 2.9.3 Global Immunoglobulin Market Volume by Region
    • 2.9.4 Global Immunoglobulin Market by Types
    • 2.9.5 Global Immunoglobulin Population by Indication
  • 2.10 Global Albumin Market
    • 2.10.1 Global Albumin Market Forecast by Value
    • 2.10.2 Global Albumin Market Forecast by Volume
    • 2.10.3 Global Albumin Market Volume by Region
  • 2.11 Global Factor VIII Market
    • 2.11.1 Global Factor VIII Market Forecast by Value
    • 2.11.2 Global Factor VIII Market Forecast by Volume
  • 2.12 Global Alpha 1 Market
    • 2.12.1 Global Alpha 1 Market Forecast by Value
  • 2.13 Global Blood Plasma Market by Region

3. Regional Analysis

  • 3.1 North America
    • 3.1.1 North America Blood Plasma Market Forecast by Value
    • 3.1.2 North America Blood Plasma Market by Type
    • 3.1.3 The US Immunoglobulin Market Forecast by Value & Volume
    • 3.1.4 The US Immunoglobulin Market Volume by Segment
    • 3.1.5 The US Albumin Market Forecast by Volume
    • 3.1.6 The US Source Plasma Collection Volume
    • 3.1.7 The US Source Plasma Collection Volume Forecast
  • 3.2 Europe
    • 3.2.1 Europe Blood Plasma Market Forecast by Value
  • 3.3 APAC
    • 3.3.1 Asia-Pacific Blood Plasma Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Recent Progress in Therapeutic Protein Drug Development
    • 4.1.2 Developments in the Production of Plasma Derivatives
    • 4.1.3 Increasing Plasma Collection
    • 4.1.4 Increase in Per Capita use of Immunoglobulin
    • 4.1.5 Rise in GDP Per Capita
    • 4.1.6 Increased Spending on Medicines
    • 4.1.7 Increasing Global Healthcare Expenditure
    • 4.1.8 Escalating Ageing Population
  • 4.2 Trends & Developments
    • 4.2.1 Increasing Fractionation Capacity
    • 4.2.2 Growing Blood Plasma Market in Emerging Economies
  • 4.3 Challenges & Issues
    • 4.3.1 High Barriers to Entry
    • 4.3.2 Challenging to Open New Plasma Centers
    • 4.3.3 High R&D Costs

5. Competitive Landscape

  • 5.1 Global Market
    • 5.1.1 Revenue and Market Cap Comparison
    • 5.1.2 Research & Development Expenditure Comparison
    • 5.1.3 Global Blood Plasma Market Share
    • 5.1.4 Global Immunoglobulin Market Share
    • 5.1.5 Global Albumin Market Share
    • 5.1.6 Global Plasma-Derived Factor VIII Market Share
    • 5.1.7 Global Alpha1 Market Share
    • 5.1.8 Growth in Plasma Collection by Leading Players
  • 5.2 The US
    • 5.2.1 The US Blood Plasma Collection Centers by Major Players
    • 5.2.2 The US Blood Plasma Collection Volume by Major Players

6. Company Profiles

  • 6.1 Takeda Pharmaceutical (Shire Plc.)
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 CSL Limited
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Grifols, S.A.
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Octapharma, Inc.
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies
  • 6.5 ADMA Biologics, Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Overview
    • 6.5.3 Business Strategies
  • 6.6 China Biologics Product Holdings
    • 6.6.1 Business Overview
    • 6.6.2 Financial Overview
    • 6.6.3 Business Strategies

List of Figures

  • Components of Blood Plasma
  • Blood Plasma Fractionation Process
  • Plasma Fractioned to Protein
  • Global Blood Plasma Market by Value (2014-2018)
  • Global Blood Plasma Market Forecast by Value (2019-2023)
  • Global Blood Plasma Fractionation Capacity (2014-2018)
  • Global Blood Plasma Fractionation Capacity Forecast (2019-2023)
  • Global Blood Plasma Fractionation Capacity by Type (2014-2018)
  • Global Blood Plasma Fractionation Capacity Forecast by Type (2019-2023)
  • Global Blood Plasma Market by Type (2018)
  • Global Blood Plasma Market Forecast by Type (2023)
  • Global Immunoglobulin Market Forecast by Value (2018-2023)
  • Global Immunoglobulin Market Forecast by Volume (2018-2023)
  • Global Immunoglobulin Market Volume by Region (2018)
  • Global Immunoglobulin Market by Types (2018)
  • Global Immunoglobulin Population by Indication (2018)
  • Global Albumin Market Forecast by Value (2018-2023)
  • Global Albumin Market Forecast by Volume (2018-2023)
  • Global Albumin Market Volume by Region (2018)
  • Global Factor VIII Market Forecast by Value (2018-2023)
  • Global Factor VIII Market Forecast by Volume (2018-2023)
  • Global Alpha 1 Market Forecast by Value (2018-2023)
  • Global Blood Plasma Market by Region (2018)
  • North America Blood Plasma Market Forecast by Value (2018-2023)
  • North America Blood Plasma Market by Type (2018)
  • The US Immunoglobulin Market Forecast by Value & Volume (2018-2023)
  • The US Immunoglobulin Market Volume by Segment (2018)
  • The US Albumin Market Forecast by Volume (2018-2023)
  • The US Source Plasma Collection Volume (2014-2018)
  • The US Source Plasma Collection Volume Forecast (2019-2023)
  • Europe Blood Plasma Market Forecast by Value (2018-2023)
  • Asia-Pacific Blood Plasma Market Forecast by Value (2018-2023)
  • Plasma Collection in the US (2014-2018)
  • Per Capita use of Immunoglobulin by Region (2018)
  • Global GDP Per Capita (2014-2018)
  • Global Spending on Medicines (2010-2020)
  • Global Healthcare Expenditure (2014-2018)
  • Global Ageing Population of 60 Years or Older (2014-2018)
  • Global Blood Plasma Market Share by Company (2018)
  • Global Immunoglobulin Market Share by Company (2018)
  • Global Albumin Market Share by Company (2018)
  • Global Plasma-Derived Factor VIII Market Share by Company (2018)
  • Global Alpha1 Market Share by Company (2018)
  • Growth in Plasma Collection by Leading Players (2014-2018)
  • The US Blood Plasma Collection Centers by Major Players (2014-2018)
  • The US Blood Plasma Collection Volume by Major Players (2014-2018)
  • Takeda Pharmaceutical Revenue Share by Product (2019)
  • Takeda Pharmaceutical Revenue Share by Geographic Region (2019)
  • Takeda Pharmaceutical Revenue and Net Profit (2015-2019)
  • CSL Limited Revenue Share by Segments (2018)
  • CSL Limited Sales and Net Profit (2014-2018)
  • Grifols, S.A. Revenue Share by Business Segments (2018)
  • Grifols, S.A. Revenue Share by Geographic Region (2018)
  • Grifols, S.A. Revenue and Profit (2014-2018)
  • Octapharma, Inc. Revenue and Net Profit (2014-2018)
  • ADMA Biologics Revenue Share by Business Segments (2018)
  • ADMA Biologics Revenue and Net Loss (2014-2018)
  • China Biologics Revenue Share by Business Segments (2018)
  • China Biologics Revenue and Net Income (2014-2018)

List of Tables

  • Blood Plasma Protein Breakup
  • Functions of Blood Plasma
  • Protein Engineering Platform Technologies (2018)
  • The US Food and Drug Administration-Approved IG Products (2018)
  • Fractionation Capacity of Key Market Players (2013-2022)
  • Key Players - Revenue & Market Cap Comparison (2018)
  • Key Players - Research & Development Expenditure Comparison (2018)
Back to Top